Net Cash Provided by (Used in) Operating Activities |
-11.6M |
USD |
-170% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
5.43M |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
450M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
80.4M |
shares |
+0.53% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-6.14M |
USD |
-202% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
48.9M |
USD |
+112% |
Q3 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
6.63M |
USD |
+16.8% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
10.3M |
USD |
-14.1% |
Q4 2023 |
FY 2023 |
Deferred Income Tax Expense (Benefit) |
4.29M |
USD |
+88.4% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
671K |
USD |
+68.6% |
Q4 2023 |
FY 2023 |
Deferred Federal Income Tax Expense (Benefit) |
4.31M |
USD |
+66.8% |
Q3 2024 |
Q3 2024 |
Current Income Tax Expense (Benefit) |
2.44M |
USD |
+261% |
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
690M |
USD |
+0.69% |
Q3 2024 |
Q3 2024 |
Current State and Local Tax Expense (Benefit) |
584K |
USD |
+1.39% |
Q3 2024 |
Q3 2024 |
Current Federal Tax Expense (Benefit) |
1.14M |
USD |
|
Q3 2024 |
Q3 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
-25K |
USD |
+91.9% |
Q3 2024 |
Q3 2024 |
Interest Expense |
37.7M |
USD |
+33.5% |
Q1 2024 |
Q1 2024 |